comparemela.com
Home
Live Updates
Study Pause - Breaking News
Pages:
Latest Breaking News On - Study pause - Page 1 : comparemela.com
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More - Disc Medicine (NASDAQ:IRON), Bristol-Myers Squibb (NYSE:BMY)
Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of clinical-stage biotechs like Disc Medicine, Inc.
United states
Bristol myers
Bristol myers squibb
European commission
Vanda pharmaceuticals
European union
Disc medicine inc
Vanda pharmaceuticals inc
Disc medicine
Most important stories
Zacks rank
Study results
Patient global impression
Study pause
Verve therapeutics
Drug approval
vimarsana © 2020. All Rights Reserved.